Company intelligence / Profile preview

Next Innovative Therapeutics

São Paulo, São Paulo, Brazilnintx.com.br ↗

Ownership: Private
Development stage: Preclinical

Overview

Nintx is a Brazilian biotech leveraging proprietary simulation and data analytics platforms to discover multi-target therapies based on Brazil’s biodiversity. It focuses on multifactorial diseases with a strong emphasis on gut microbiome-mediated mechanisms. As of December 2024, it has raised $10 million Series A funding to accelerate R&D across eight new drug programs in partnership with industry and academic collaborators. All programs are preclinical; none have reached IND or clinical trial stage yet. The business model centers around outlicensing candidates post-preclinical development.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Multi-target therapies derived from natural products, especially plant-based compounds from Brazilian biodiversity.Focus on multi-target approaches for multifactorial diseases, including those mediated by the human gut microbiome.
Industry: Biotech

Drug pipeline

2 assets

NTX-01

Pre-clinical

Indications: Cardiometabolic disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Adeste (industry partner)Centroflora (industry partner)CIEnPCNPEM/Sirius particle accelerator facility (academic/research partners)Tiaraju (strategic investor/partner)

Beyond the preview

Go deeper on Next Innovative Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Next Innovative Therapeutics.

Explore the full profile